https://www.h2founders.com/en/hello-world/2026-01-04T21:48:05+00:00https://www.h2founders.com/en/the-future-of-marketing-automation/2026-01-04T22:18:26+00:00https://www.h2founders.com/en/is-influencer-marketing-still-worth-it-strategies-for-2024/2026-01-04T20:25:33+00:00https://www.h2founders.com/en/how-we-helped-a-fashion-brand-achieve-their-goal/2026-01-04T18:48:05+00:00https://www.h2founders.com/en/how-analytics-can-fuel-your-marketing-success/2026-01-04T22:29:38+00:00https://www.h2founders.com/en/the-ultimate-guide-to-2024-social-media-marketing-trends/2026-01-04T22:37:02+00:00https://www.h2founders.com/en/conquering-the-marketing-maze-creative-strategies-on-a-budget/2026-01-04T22:09:46+00:00https://www.h2founders.com/en/hello-world-2/2026-01-04T19:28:26+00:00https://www.h2founders.com/en/alzheimers-dementia-breakthrough-czech-patient-friendly-solution-turns-problem-into-opportunity-and-investors-dont-want-to-miss-out/2026-01-04T21:39:35+00:00https://www.h2founders.com/en/forever-young-h2-global-group-brings-a-hydrogen-standard-to-the-field-of-longevity/2026-01-04T21:30:59+00:00https://www.h2founders.com/en/alzheimers-dementia-and-longevity-h2-global-group-offers-a-solution-opens-an-investment-window-and-targets-the-medicine-of-the-future/2026-01-04T21:16:11+00:00https://www.h2founders.com/en/authority-in-the-field-of-molecular-hydrogen/2026-02-24T10:37:44+00:00https://www.h2founders.com/en/japanese-professor-shigeo-ohta-on-alzheimers-dementia-why-we-do-what-we-do-they-wrote-about-us-as-well/2026-02-24T10:39:05+00:00https://www.h2founders.com/en/science-that-makes-sense-molecular-hydrogen-as-an-investment-in-health-and-the-future/2026-02-24T10:40:04+00:00https://www.h2founders.com/en/the-clinical-study-has-been-launched/2026-02-24T10:46:24+00:00https://www.h2founders.com/en/molecular-hydrogen-on-the-path-to-modern-medicine/2026-02-24T10:47:10+00:00https://www.h2founders.com/en/czechs-have-a-more-open-path-to-investing-in-the-medicine-of-the-future-why-capital-is-moving-into-medtech-healthtech-mental-health-and-longevity/2026-02-24T10:49:17+00:00https://www.h2founders.com/en/molecular-hydrogen-not-only-against-alzheimers-dementia-the-medicine-of-the-future/2026-02-24T10:50:14+00:00https://www.h2founders.com/en/dementia-is-not-just-one-persons-diagnosis/2026-02-24T10:51:17+00:00https://www.h2founders.com/en/do-you-forget-things-often-did-you-know-it-could-be-a-precursor-to-alzheimers-dementia/2026-02-24T13:45:20+00:00https://www.h2founders.com/en/investment-boom-in-czech-medtech-h2-global-group-with-a-japanese-patent-and-a-pre-money-valuation-of-czk-1-6-billion-opens-the-door-to-investors/2026-03-03T12:57:39+00:00https://www.h2founders.com/en/ales-valenta-from-olympic-gold-to-a-hydrogen-investment-opportunity/2026-03-11T09:07:19+00:00https://www.h2founders.com/en/where-are-the-best-investment-prospects-in-times-of-turbulent-uncertainty-smart-capital-is-targeting-the-medicine-of-the-future/2026-03-20T12:32:53+00:00https://www.h2founders.com/en/a-strong-signal-for-investors-vr-life-and-h2-global-group-confirm-the-value-of-czech-medtech-innovations/2026-03-28T12:33:45+00:00https://www.h2founders.com/en/strong-signal-for-investors-vr-life-and-h2-global-group-validate-the-value-of-european-medtech-innovation/2026-04-07T10:27:35+00:00https://www.h2founders.com/en/military-and-emergency-services-in-focus-european-medtech-innovation-with-japanese-roots-sends-a-strong-signal-to-investors-and-partners/2026-04-10T10:02:03+00:00